These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 10430074

  • 1. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
    Clayman GL, Frank DK, Bruso PA, Goepfert H.
    Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL.
    Cancer Res; 1995 Jul 15; 55(14):3117-22. PubMed ID: 7606733
    [Abstract] [Full Text] [Related]

  • 3. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
    Frank DK, Frederick MJ, Liu TJ, Clayman GL.
    Clin Cancer Res; 1998 Oct 15; 4(10):2521-8. PubMed ID: 9796986
    [Abstract] [Full Text] [Related]

  • 4. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 15; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

  • 5. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H, Clayman GL.
    Cancer Res; 1994 Jul 15; 54(14):3662-7. PubMed ID: 8033080
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
    Eicher SA, Clayman GL, Liu TJ, Shillitoe EJ, Storthz KA, Roth JA, Lotan R.
    Clin Cancer Res; 1996 Oct 15; 2(10):1659-64. PubMed ID: 9816113
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J.
    Curr Opin Mol Ther; 1999 Aug 15; 1(4):500-9. PubMed ID: 11713766
    [Abstract] [Full Text] [Related]

  • 8. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ.
    Cancer Res; 1995 Jan 01; 55(1):1-6. PubMed ID: 7805018
    [Abstract] [Full Text] [Related]

  • 9. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Zhu GY, Xu B.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 01; 27(7):426-8. PubMed ID: 16188130
    [Abstract] [Full Text] [Related]

  • 10. All-trans-retinoic acid enhances the effect of adenovirus-mediated wild-type p53 gene transfer in head and neck squamous cell carcinoma.
    Nakashima T, Sun SY, Lotan R, Fujiwara T, Yasumatsu R, Komiyama S, Clayman GL.
    Laryngoscope; 2001 Aug 01; 111(8):1459-64. PubMed ID: 11568584
    [Abstract] [Full Text] [Related]

  • 11. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
    Edelman J, Edelman J, Nemunaitis J.
    Curr Opin Mol Ther; 2003 Dec 01; 5(6):611-7. PubMed ID: 14755887
    [Abstract] [Full Text] [Related]

  • 12. Clinical trails referral resource. Clinical trials of adenovirus-p53 gene therapy.
    Zwiebel JA, Nagler C, Smiley JK, Cheson BD.
    Oncology (Williston Park); 1998 Aug 01; 12(8):1172, 1175. PubMed ID: 11236309
    [No Abstract] [Full Text] [Related]

  • 13. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
    Morris JC, Wildner O.
    Mol Ther; 2000 Jan 01; 1(1):56-62. PubMed ID: 10933912
    [Abstract] [Full Text] [Related]

  • 14. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D, Duan L, Freimuth P, O'Malley BW.
    Clin Cancer Res; 1999 Dec 01; 5(12):4175-81. PubMed ID: 10632357
    [Abstract] [Full Text] [Related]

  • 15. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy.
    Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M.
    Clin Cancer Res; 2003 Jan 01; 9(1):93-101. PubMed ID: 12538456
    [Abstract] [Full Text] [Related]

  • 16. The current status of gene therapy.
    Clayman GL.
    Semin Oncol; 2000 Aug 01; 27(4 Suppl 8):39-43. PubMed ID: 10952437
    [Abstract] [Full Text] [Related]

  • 17. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 01; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 18. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T, Tofilon PJ, Schaefer TS, Parikh D, Liu TJ, Lang FF.
    Cancer Res; 2002 Feb 15; 62(4):1069-76. PubMed ID: 11861384
    [Abstract] [Full Text] [Related]

  • 19. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.
    Clayman GL, el-Naggar AK, Lippman SM, Henderson YC, Frederick M, Merritt JA, Zumstein LA, Timmons TM, Liu TJ, Ginsberg L, Roth JA, Hong WK, Bruso P, Goepfert H.
    J Clin Oncol; 1998 Jun 15; 16(6):2221-32. PubMed ID: 9626224
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin].
    Fujiwara T, Ogawa N, Kagawa S, Nishizaki M, Yasuda T, Tanaka N, Orita K, Roth JA.
    Gan To Kagaku Ryoho; 1996 Jul 15; 23(8):1085-8. PubMed ID: 8687228
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.